HAIHE BIOPHARMA
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.
HAIHE BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2011-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.haihepharma.com
Total Employee:
251+
Status:
Active
Contact:
86-(021)-20568888
Total Funding:
317.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Apache Mobile Non Scaleable Content Euro Microsoft Azure DNS ASP.NET
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Intech Biopharm
Intech Biopharm is a pharmaceutical company that develops, produces and markets specialized drugs focused on respiratory treatment.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Employees Featured
Jian Ding Chairman @ Haihe Biopharma
Chairman
Ruiping Dong CEO @ Haihe Biopharma
CEO
Founder
Investors List
CICC
CICC investment in Series B - Haihe Biopharma
Warburg Pincus
Warburg Pincus investment in Series B - Haihe Biopharma
Legend Capital
Legend Capital investment in Series B - Haihe Biopharma
Beijing Langzi Asiana Asset Management
Beijing Langzi Asiana Asset Management investment in Series B - Haihe Biopharma
Winfast Holding
Winfast Holding investment in Series B - Haihe Biopharma
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Haihe Biopharma
Chaos Investment
Chaos Investment investment in Series B - Haihe Biopharma
CASVC
CASVC investment in Series B - Haihe Biopharma
Huagai Capital
Huagai Capital investment in Series B - Haihe Biopharma
Daehwa Pharmaceutical
Daehwa Pharmaceutical investment in Series B - Haihe Biopharma
Official Site Inspections
http://www.haihepharma.com
- Host name: 101.32.242.105
- IP address: 101.32.242.105
- Location: Singapore
- Latitude: 1.3667
- Longitude: 103.8
- Timezone: Asia/Singapore
More informations about "Haihe Biopharma"
上海海和药物研究开发股份有限公司|海和药物|海和官网
院士 1位 科研人员 141人 博士 29位 员工人数 233人 硕士 61位 截止2024.02.29See details»
上海海和药物研究开发股份有限公司|海和药物|海和官网
Haihe Biopharma is an innovation-driven biotechnology company in China focusing on the discovery, development, production and commercialization of innovative anti-tumor drugs. …See details»
Haihe Biopharma - Crunchbase Company Profile
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The …See details»
haihepharma.com - 海和製薬株式会社
海和製薬株式会社 Inclusive and open to diversity, innovation oriented to win together and benefit the mankind. Haihe Biopharma は革新的な抗腫瘍薬の発見、開発、生産、及び商業化を目指すグローバルバイオテクノロジー企業です。 …See details»
Haihe Biopharma 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Haihe Biopharma. Use the PitchBook Platform to explore the full profile.See details»
Haihe Biopharma - Craft
Haihe Biopharma is a company that develops anti-tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company provides products including …See details»
Haihe Biopharma Co., Ltd. - Drug pipelines, Patents, Clinical trials ...
Haihe Pharmaceutical R&D Co., Ltd, a premier biotechnology company in China, focuses on the finding, development, manufacturing, and commercialization of innovative cancer drugs. They …See details»
Haihe Biopharma Overview | SignalHire Company Profile
Haihe Biopharma is a private company that has been in the industry for 13 years. The company currently specializes in the Hospital & Health Care, Biotechnology, Pharmaceuticals areas. …See details»
上海海和药物研究开发股份有限公司|海和药物|海和官网
1 product – Gumarontinib, an oral highly selective mesenchymal-epithelial transition (MET) inhibitor and a Category 1 innovative new chemical drug has been conditionally approved by NMPA that Haihe owns its global intellectual …See details»
Haihe Biopharma - VentureRadar
"HaiHe Biopharma focuses on discovery, development and commercialization of innovative anti-tumor drugs. Guided by our mission, “Inclusive and open to diversity, innovation oriented to …See details»
上海海和药物研究开发股份有限公司|海和药物|海和官网
海和药物是中国领先的自主创新生物技术公司，专注于抗肿瘤创新药物的发现、开发、生产及商业化，为全球癌症患者带来 ...See details»
Haihe Biopharma - Overview, News & Similar companies - ZoomInfo
View Haihe Biopharma (www.haihepharma.com) location in Shanghai, China , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Haihe Pharmaceutical - Warburg Pincus
Haihe Pharmaceutical focuses on discovery, development and commercialization of innovative anti-tumor drugs. Led by an academician of the Chinese Academy of Engineering and a senior …See details»
HaiHe Biopharma - Company Profile - Tracxn
Feb 21, 2025 HaiHe Biopharma - Developer of reformulations for cancer treatment. Raised a total funding of $333M over 3 rounds from 21 investors.See details»
Haihe Biopharma Co., Ltd. (上海海和药物研究开发股份有限公司)
了解Haihe Biopharma Co., Ltd. (上海海和药物研究开发股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的46项临床试验, 5篇新闻和5篇文献，疾病领域:肿瘤，神经系统疾病，血 …See details»
上海海和药物研究开发股份有限公司|海和药物|海和官网
Many of our investigational products are independently developed and possessed global rights. We are open to potential discussions with overseas pharmaceutical and biotechnology …See details»
Digital Health Corporate Profiles - HealthTech Alpha
HaiHe Biopharma is a Pharmaceutical focused corporation. Discover Digital Health profiles, team, funding and valuation with HealthTech Alpha.See details»
Shanghai HaiHe Pharmaceutical Co., Ltd. | Insights
Mar 17, 2025 A dearth of innovative drug developers seeking public listings on China’s Nasdaq-like STAR Market has made investors scratch their heads, as the bourse, hailed as the …See details»
上海海和药物研究开发股份有限公司|海和药物|海和官网
1 product – Gumarontinib, an oral highly selective mesenchymal-epithelial transition (MET) inhibitor and a Category 1 innovative new chemical drug has been conditionally approved by …See details»
News Center - haihepharma.com
According to the World Health Organization (WHO) "Global Tuberculosis Report 2020" data, there were approximately 465,000 new rifampicin-resistant tuberculosis cases worldwide in 2019, of …See details»